Literature DB >> 23815863

Essential genes in thyroid cancers: focus on fascin.

Hilda Samimi1, Majid Zaki Dizaji, Mohsen Ghadami, Abolhasan Shahzadeh Fazeli, Patricia Khashayar, Masoud Soleimani, Bagher Larijani, Vahid Haghpanah.   

Abstract

Although thyroid cancers are not among common malignancies, they rank as the first prevalent endocrine cancers in human. According to the results of published studies it has been shown the gradual progress from normal to the neoplastic cell in the process of tumor formation is the result of sequential genetic events. Among them we may point the mutations and rearrangements occurred in a group of proto-oncogenes, transcription factors and metastasis elements such as P53, RAS,RET,BRAF, PPARγ and Fascin. In the present article,we reviewed the most important essential genes in thyroid cancers, the role of epithelial mesenchymal transition and Fascin has been highlighted in this paper.

Entities:  

Year:  2013        PMID: 23815863      PMCID: PMC7983713          DOI: 10.1186/2251-6581-12-32

Source DB:  PubMed          Journal:  J Diabetes Metab Disord        ISSN: 2251-6581


  82 in total

1.  A pooled analysis of thyroid cancer studies. V. Anthropometric factors.

Authors:  L Dal Maso; C La Vecchia; S Franceschi; S Preston-Martin; E Ron; F Levi; W Mack; S D Mark; A McTiernan; L Kolonel; K Mabuchi; F Jin; G Wingren; M R Galanti; A Hallquist; E Glattre; E Lund; D Linos; E Negri
Journal:  Cancer Causes Control       Date:  2000-02       Impact factor: 2.506

2.  AACE/AAES medical/surgical guidelines for clinical practice: management of thyroid carcinoma. American Association of Clinical Endocrinologists. American College of Endocrinology.

Authors:  R H Cobin; H Gharib; D A Bergman; O H Clark; D S Cooper; G H Daniels; R A Dickey; D S Duick; J R Garber; I D Hay; J S Kukora; H M Lando; A B Schorr; M A Zeiger
Journal:  Endocr Pract       Date:  2001 May-Jun       Impact factor: 3.443

3.  Survivin gene polymorphism association with papillary thyroid carcinoma.

Authors:  Nasrin Yazdani; Forough A Sayahpour; Vahid Haghpanah; Parvin Amiri; Maryam Shahrabi-Farahani; Mehran Moradi; Arienne Mirmiran; Mohammad-Taghi Khorsandi; Bagher Larijani; Leila V Mostaan; Mahsa M Amoli
Journal:  Pathol Res Pract       Date:  2012-01-30       Impact factor: 3.250

4.  Prognostic factors for thyroid carcinoma. A population-based study of 15,698 cases from the Surveillance, Epidemiology and End Results (SEER) program 1973-1991.

Authors:  F D Gilliland; W C Hunt; D M Morris; C R Key
Journal:  Cancer       Date:  1997-02-01       Impact factor: 6.860

5.  PAX8-PPARgamma rearrangement in thyroid tumors: RT-PCR and immunohistochemical analyses.

Authors:  Marina N Nikiforova; Paul W Biddinger; Christy M Caudill; Todd G Kroll; Yuri E Nikiforov
Journal:  Am J Surg Pathol       Date:  2002-08       Impact factor: 6.394

6.  Gene p53 mutations are restricted to poorly differentiated and undifferentiated carcinomas of the thyroid gland.

Authors:  R Donghi; A Longoni; S Pilotti; P Michieli; G Della Porta; M A Pierotti
Journal:  J Clin Invest       Date:  1993-04       Impact factor: 14.808

7.  Expression of fascin-1, the gene encoding the actin-bundling protein fascin-1, during mouse embryogenesis.

Authors:  Adèle De Arcangelis; Elisabeth Georges-Labouesse; Josephine C Adams
Journal:  Gene Expr Patterns       Date:  2004-10       Impact factor: 1.224

8.  A new oncogene in human thyroid papillary carcinomas and their lymph-nodal metastases.

Authors:  A Fusco; M Grieco; M Santoro; M T Berlingieri; S Pilotti; M A Pierotti; G Della Porta; G Vecchio
Journal:  Nature       Date:  1987 Jul 9-15       Impact factor: 49.962

9.  Anaplastic thyroid carcinoma: risk factors and outcome.

Authors:  J G Demeter; S A De Jong; A M Lawrence; E Paloyan
Journal:  Surgery       Date:  1991-12       Impact factor: 3.982

10.  p53 gene mutations associated with anaplastic transformation of human thyroid carcinomas.

Authors:  T Nakamura; I Yana; T Kobayashi; E Shin; K Karakawa; S Fujita; A Miya; T Mori; I Nishisho; S Takai
Journal:  Jpn J Cancer Res       Date:  1992-12
View more
  2 in total

1.  Investigation of promoter methylation of FSCN1 gene and FSCN1 protein expression in differentiated thyroid carcinomas.

Authors:  Mojdeh Mahdiannasser; Vahid Haghpanah; Elia Damavandi; Majid Kabuli; Seyed Mohammad Tavangar; Bagher Larijani; Mohsen Ghadami
Journal:  Mol Biol Rep       Date:  2020-02-18       Impact factor: 2.316

2.  Antisense-miR-21 enhances differentiation/apoptosis and reduces cancer stemness state on anaplastic thyroid cancer.

Authors:  Vahid Haghpanah; Parviz Fallah; Rezvan Tavakoli; Mahmood Naderi; Hilda Samimi; Masoud Soleimani; Bagher Larijani
Journal:  Tumour Biol       Date:  2015-08-20
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.